QUOTE AND NEWS
StreetInsider.com  3 hrs ago  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Perrigo+%28PRGO%29+Confirms+AB+Therapeutic+Equivalent+Rating+From+The+FDA+For+Its+Testosterone+Gel+1.0%25/9687681.html for the full story.
Market Intelligence Center  8 hrs ago  Comment 
Perrigo (PRGO) closed Wednesday at $157.28 and technical indicators recently have been bullish. Based in part on those numbers, MarketIntelligenceCenter.com's patented algorithms have identified a couple of attractive trading opportunities in...
Forbes  Jul 22  Comment 
Looking at the sectors faring best as of midday Tuesday, shares of Healthcare companies are outperforming other sectors, up 1.1%. Within the sector, Waters (NYSE: WAT) and Perrigo Company (NYSE: PRGO) are two of the day's stand-outs, showing a...
FiercePharma  Jul 16  Comment 
OTC generics maker Perrigo could be the next tax-advantaged company in line for a buyout. And while Perrigo hasn't confirmed any M&A plans, speculation has been enough to send shares soaring.
TheStreet.com  Jul 15  Comment 
NEW YORK (TheStreet) -- Perrigo  shares are down -2.4% to $154.97 on heavy volume today following a note by Jefferies analysts saying that anticipation about the possible sale of the over-the-counter drug manufacturer should be tempered.The firm...
Benzinga  Jul 14  Comment 
Perrigo Company (NYSE: PRGO) gained seven percent in Monday morning action after an Israeli business news site said it may be acquired by a competitor. Globes said the over-the-counter drugmaker hired an investment banker and "market sources"...
StreetInsider.com  Jul 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Perrigo+%28PRGO%29+Approved+for+Generic+Advil+Congestion+Relief+Tabs/9644196.html for the full story.
Market Intelligence Center  Jun 24  Comment 
Perrigo (PRGO) presents a trading opportunity that offers a 3.24% return in just 53 days. A covered call on Perrigo at the $140.00 level expiring on Aug. '14 offers an assigned return rate of 3.24% or 22.35% annualized. This trade offers 6.03%...




 

Perrigo Company is a global health-care supplier and the world's largest manufacturer of over-the-counter pharmaceuticals for the store brand market. The company develops, distributes, and manufactures over-the-counter and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients, and consumer products.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki